The group is researching methods which can contribute to further mapping and treatment of patients suffering from hereditary heart disease.
Prevention of sudden cardiac death (SCD) is a major challenge in cardiology. Young individuals with cardiac genetic diseases are predisposed to SCD, and risk stratification is vital in these patients. Ongoing research is focusing on characterization of cardiac function and prediction of life-threatening ventricular arrhythmias in patients at risk of SCD.
Better risk assessment will provide a stronger selection of patients with high risk of death. At-risk individuals may receive preventive drug treatment, and those with highest risk may receive an implantable cardioverter defibrillator.
Our research group has collaboration with several institutions and medical technology providers.
- GE Healthcare